RxSight's 15min chart triggers KDJ Golden Cross, Bullish Marubozu signal.

The 15-minute chart for RxSight has recently triggered a Golden Cross in the KDJ indicator, accompanied by a Bullish Marubozu at 09/25/2025 16:00. This indicates that the momentum of the stock price is shifting towards the upside and has the potential to continue increasing. As buyers are in control of the market, it is likely that bullish momentum will persist.

NEW YORK, Sept. 12, 2025 — RxSight Inc. (NASDAQ: RXST), a biopharmaceutical company, is facing a class action lawsuit alleging securities fraud. The lawsuit, filed by Bronstein, Gewirtz & Grossman, LLC, claims that RxSight made materially false and misleading statements about its business, operations, and prospects during a specific period. The complaint, filed on September 21, 2025, alleges that the company failed to disclose significant issues, including adoption challenges, overstated demand for its products, and the likelihood of missing financial guidance for fiscal year 2025 RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit^[1].

The lawsuit seeks damages on behalf of investors who purchased RxSight securities between November 7, 2024, and July 8, 2025. Affected investors are encouraged to join the case by visiting the firm’s website RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit^[1].

Separately, technical indicators suggest a potential shift in the stock's momentum. On September 25, 2025, at 16:00, the 15-minute chart for RxSight triggered a Golden Cross in the KDJ indicator, accompanied by a Bullish Marubozu. This combination indicates a potential upward shift in the stock price, with buyers in control of the market. Traders and investors should closely monitor the stock's performance to gauge the sustainability of this bullish momentum .